Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

VistaGen Therapeutics, Inc.

TRADE

NASDAQ: VTGNHealthcare / Drug Manufacturers - Other / California, U.S.A
2.11+0.12+6.03%Vol 175 7891Y Perf 59.24%
Oct 18th, 2018 11:08
BID2.10 ASK2.11
Open2.08 Previous Close1.99
Pre-Market2.08 After-Trading1.99
 0.09 4.52%  - -%
Target Price
11.33 
Analyst Rating
Strong Buy 1.00
Potencial %
439.52 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)54 
Earnings Rating
Neutral
Price Range Ratio 52wk %
72.45 
Earnings Date
8th Nov 2018

Today's Price Range

2.002.17

 

52wk Range

0.692.65

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
49.62%
3 Months
47.41%
6 Months
73.04%
1 Year
59.24%
3 Years
-75.13%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTGN2.110.12006.03
AAPL218.71-2.4800-1.12
GOOG1 100.91-14.7800-1.32
MSFT109.46-1.2500-1.13
XOM82.060.56000.69
WFC53.96-0.5000-0.92
JNJ138.81-0.6500-0.47
FB156.71-2.7100-1.70
GE12.350.16001.31
JPM109.44-0.3900-0.36
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.90
Current Ratio 4.20
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.06
Interest Coverage -1 829.60
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-211.00
EBITDA Margin-210.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 11.15
PS Ratios 19.23
Price to Cash Flow -
Price to Free Cash Flow -3.60
Cash Flow Per Share -0.43
Price to Tangible Book11.15
Book Value per Share0.12
Enterprise Value (in ths.)28 849
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)247.74
ROE last 12 Months -1 346.50
Return on Assets (5Y Avg) -357.16
ROA last 12 Months -328.29
Return on Capital (5Y Avg) -
ROC last 12 Months -1 178.51
Return on invested Capital Q -86.40
Return on invested Capital Y-406.48
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.20-
Q04 2018-0.28-0.1932.14
Q03 2018--0.24-
Q02 2018--0.53-
Q01 2018--0.28-
Q04 2017--0.32-
Q03 2017--0.34-
Q02 2017--0.42-
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.1982.57Positive
12/2018 QR-0.1986.62Positive
3/2019 FY-0.75--
3/2020 FY-0.99--
Next Report Date8th Nov 2018
Estimated EPS Next Report-0.19
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume175 789
Shares Outstanding (in ths.)25 820
Trades Count219
Dollar Volume350 790
Avg. Volume718 918
Avg. Weekly Volume828 539
Avg. Monthly Volume1 106 640
Avg. Quarterly Volume447 657

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

54%46%

Bearish Bullish

61%39%

Bearish Bullish

46%54%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x